Literature DB >> 2258376

Thinking about stopping treatment for panic disorder.

R L DuPont1.   

Abstract

The lifelong nature of panic disorder and the development of effective new treatments have focused attention on long-term use of antipanic medications, particularly benzodiazepines and their possibly addictive nature. Benzodiazepines are generally safe and effective. An understanding of the distinction between chemical dependence and physical dependence places problems involved in the use and discontinuation of benzodiazepines into perspective. Patients with a dual diagnosis of panic disorder and chemical dependence are at risk of addiction. Others may develop physical dependence but are able to discontinue benzodiazepine treatment when panic symptoms subside. The approach to benzodiazepine use and discontinuation should be different for patients with chemical dependence as opposed to patients with physical dependence. A four-step approach to discontinuation that is applicable to both groups is offered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258376

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  3 in total

1.  Clinical and economic evaluation of benzodiazepines: a value analysis.

Authors:  J S Lyons; D B Larson; J Hromco
Journal:  Pharmacoeconomics       Date:  1992-11       Impact factor: 4.981

2.  Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.

Authors:  Michael W Otto; R Kathryn McHugh; Naomi M Simon; Frank J Farach; John J Worthington; Mark H Pollack
Journal:  Behav Res Ther       Date:  2010-04-28

Review 3.  Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review.

Authors:  André S Pollmann; Andrea L Murphy; Joel C Bergman; David M Gardner
Journal:  BMC Pharmacol Toxicol       Date:  2015-07-04       Impact factor: 2.483

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.